Section 55
Chapter 54,509

Murine mPGES-1 3D structure elucidation and inhibitors binding mode predictions by homology modeling and site-directed mutagenesis

Corso, G.; Coletta, I.; Ombrato, R.

Journal of Chemical Information and Modeling 53(7): 1804-1817


ISSN/ISBN: 1549-960X
PMID: 23789712
DOI: 10.1021/ci400180f
Accession: 054508591

Download citation:  

Microsomal prostaglandin E synthase-1 (mPGES-1) constitutes an inducible glutathione-dependent integral membrane protein that catalyzes the oxido-reduction of cyclooxygenase derived PGH₂ into PGE₂. mPGES-1 is an essential enzyme involved in a variety of human diseases or pathological conditions, such as rheumatoid arthritis, fever, and pain; it is therefore regarded as a primary target for development of next-generation anti-inflammatory drugs. Several compounds targeting human mPGES-1 have been reported in the literature. However, none of them is really specific for mPGES-1, and quite surprisingly, all of these compounds have very low or no activity against murine mPGES-1, making preclinical development hard and very expensive. In order to overcome this unresolved question, the current study focuses on the elucidation of the molecular determinants of murine mPGES-1 ligand binding modes combining protein homology modeling and site-directed mutagenesis approaches. We have developed, for the first time, two murine mPGES-1 models, describing both the closed and the open/active conformation of the enzyme. The 3D structure of human mPGES-1 having been recently disclosed, the main differences between the human and the murine enzyme models are described, emphasizing the smaller dimensions of the rodent substrate binding site, which could account for different activity of a ligand toward the two species. Furthermore, active binding modes are hypothesized, highlighting the most likely important residues for inhibition activity, whose identification is supported by in-house mutagenesis experiments. The results of our work could provide grounds for a rational structure-based drug design aimed to identify new inhibitors active against both human and murine mPGES-1.

PDF emailed within 0-6 h: $19.90